SPIE Translational Biophotonics is organizing a new workshop for the 19th and 20th of May on Rice University’s campus in Houston, Texas.
The idea behind the workshop is to foster accelerated creation and deployment of test and treatment approaches for cancer as well as other serious diseases to patients that are more accurate and less invasive. In border to achieve this, the event planners are bringing together representatives of three communities — academics, industry R&D leaders, and practicing clinicians — for presentations on technologies with applications in cancer diagnostics, cardiovascular imaging, and detection of infectious diseases.
“This new event will serve as an interdisciplinary forum for academics, developers, and practicing clinicians working in fields of medicine and biophotonics, such as optical diagnostics, image-guided intervention, novel microscopy techniques, and probes – in conjunction with system designers and developers,” said conference chair Tomasz Tkaczyk in a press release. Dr. Tkaczyk goes on to explain that the key to expediting improved treatment for patients is bringing together everyone with a role in the technology transfer path, from research to commercialization. This interdisciplinary group includes specialists in cancer diagnostics, cardiovascular imaging professionals, and specialists in detecting infectious diseases.
Organized by SPIE and the Department of Bioengineering of Rice University, and sponsored by SPIE, the international society for optics and photonics, and the BioScience Research Collaborative of Rice University, over sixty informative lectures and poster sessions will be presented over the course of the two-day event. A special focus on leaders in biophotonics will discuss the professional and academic paths that led to their advancements in the field, and will also plot new directions for the future of optical imaging for both research and clinical applications. Clinicians will also offer their perspectives on application needs, while industry representatives will discuss pathways to biophotonics commercialization.
In addition, panelists and presenters will also discuss topics such as diagnostic imaging and detection (endoscopies, diffused imaging, spectroscopy); new techniques in microscopy and other emerging techniques (super resolution techniques, contrasts for microscopy, in vivo imaging); analytical systems (microarrays, high-throughput detection); MD perspectives (unmet clinical needs); and industry perspectives (the implementation process, device success stories).
SPIE is the international society for the study and support of optics and photonics research and development. Founded in 1955, this not-for-profit society seeks to advance an interdisciplinary approach to the science and application of light. The society offers conferences, continuing education, books, journals, and a digital library in support of emerging technologies through interdisciplinary information exchange, continuing education, professional networking, and patent precedent. SPIE provided $3.2 million in support of education and outreach programs in 2013.